Research Article
Prealbumin-to-Globulin Ratio Can Predict the Chemotherapy Outcomes and Prognosis of Patients with Gastric Cancer Receiving First-Line Chemotherapy
Table 5
Correlations between survival and AGR and other clinicopathological factors.
| | Progression-free survival | Overall survival | Univariate analysis | | | Multivariate analysis | | | Univariate analysis | | | Multivariate analysis | | | Hazard ratio | 95% CI | value | Hazard ratio | 95% CI | value | Hazard ratio | 95% CI | value | Hazard ratio | 95% CI | value |
| Sex (male) | 1.073 | 0.835-1.379 | 0.582 | | | | 1.145 | 0.891-1.471 | 0.290 | | | | Age (>60 years) | 0.991 | 0.781-1.256 | 0.939 | | | | 0.797 | 0.627-1.012 | 0.062 | 0.877 | 0.678-1.135 | 0.320 | Body mass index (<18.5 or >25 kg/m2) | 0.923 | 0.705-1.207 | 0.558 | | | | 1.084 | 0.828-1.420 | 0.557 | | | | ECOG (≥2) | 1.124 | 0.823-1.535 | 0.463 | | | | 1.174 | 0.859-1.604 | 0.313 | | | | Histological type (poorly cohesive, mucinous) | 1.492 | 1.136-1.959 | 0.004 | 1.355 | 1.028-1.787 | 0.031 | 1.537 | 1.172-2.015 | 0.002 | 1.352 | 1.023-1.787 | 0.034 | TNM stage (IV) | 1.206 | 0.897-1.622 | 0.214 | | | | 1.368 | 1.017-1.839 | 0.038 | 1.182 | 0.852-1.640 | 0.318 | Number of organs affected by metastasis (≥2) | 1.390 | 1.081-1.786 | 0.010 | 1.341 | 1.030-1.746 | 0.029 | 1.364 | 1.058-1.758 | 0.017 | 1.299 | 0.977-1.728 | 0.072 | Peritoneal metastasis (yes) | 1.526 | 1.185-1.966 | <0.001 | 1.239 | 0.947-1.621 | 0.118 | 1.710 | 1.325-2.205 | <0.001 | 1.419 | 1.056-1.907 | 0.020 | CEA (>5 ng/mL) | 1.222 | 0.959-1.557 | 0.105 | 1.146 | 0.883-1.487 | 0.305 | 1.278 | 1.004-1.626 | 0.046 | 1.381 | 1.066-1.787 | 0.014 | CA72-4 (>6 U/mL) | 1.425 | 1.118-1.816 | 0.004 | 1.418 | 1.093-1.840 | 0.009 | 1.254 | 0.989-1.590 | 0.061 | 1.150 | 0.891-1.485 | 0.284 | CA19-9 (>37 U/mL) | 1.051 | 0.825-1.339 | 0.686 | | | | 1.046 | 0.821-1.332 | 0.717 | | | | Hemoglobin (<115 g/L) | 0.905 | 0.708-1.157 | 0.424 | | | | 0.890 | 0.697-1.136 | 0.349 | | | | AGR ≥1.46 | 0.419 | 0.328-0.535 | <0.001 | 0.454 | 0.353-0.583 | <0.001 | 0.584 | 0.460-0.742 | <0.001 | 0.602 | 0.472-0.769 | <0.001 |
|
|
ECOG: Eastern Cooperative Oncology Group; TNM: tumor-node-metastasis; CEA: carcinoembryonic antigen; CA72-4: carbonhydrate antigen 72-4; CA 19-9: carbohydrate antigen 19-9; AGR: albumin-to-globulin ratio.
|